Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2020

Nov 17, 2020

32227_dirs_2020-11-16_3facac5a-62a3-42f4-88c7-8a29601c310d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2020-11-12

Reporting Person: VAN OORT DOUGLAS M (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-12 Common Stock M 121248 $7.52 Acquired 2384038 Direct
2020-11-12 Common Stock S 121248 $42.18 Disposed 2262790 Direct
2020-11-13 Common Stock M 358752 $7.52 Acquired 2621542 Direct
2020-11-13 Common Stock S 118752 $41.56 Disposed 2502790 Direct
2020-11-16 Common Stock M 20000 $7.52 Acquired 2522790 Direct
2020-11-16 Common Stock S 100000 $42.34 Disposed 2422790 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-12 Stock Option (Right to Buy) $7.52 M 121248 Disposed 2022-04-28 Common Stock (121248.0) Direct
2020-11-13 Stock Option (Right to Buy) $7.52 M 358752 Disposed 2022-04-28 Common Stock (358752.0) Direct
2020-11-16 Stock Option (Right to Buy) $7.52 M 20000 Disposed 2022-04-28 Common Stock (20000.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 15000 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $8.03 2023-02-26 Common Stock (500000.0) 500000 Direct
Stock Option (Right to Buy) $19.6 2024-03-01 Common Stock (231567.0) 231567 Direct
Stock Option (Right to Buy) $28.33 2027-03-02 Common Stock (225084.0) 225084 Direct

Footnotes

F1: On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.

F2: On February 26, 2018, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F3: On March 1, 2019, Mr. VanOort was granted 231,567 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F4: On March 2, 2020, Mr. VanOort was granted 225,084 stock options. These options vest ratably over the first four anniversary dates of the grant date.